Al-Tawfiq, J. A., & Saadeh, B. M. (2011). Improving adherence to venous thromoembolism prophylaxis using multiple interventions. Annals of Thoracic Medicine, 6(2), 82.

Anderson, F. A., Wheeler, H. B., Goldberg, R. J., Hosmer, D. W., Forcier, A., & Patwardhan, N. A. (1994). Changing clinical practice: prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Archives of Internal Medicine, 154(6), 669–677.

Bouillaud, S., & Bouillaud, J. (1823). De l’Obliteration des veines et de son influence sur la formation des hydropisies partielles: consideration sur la hydropisies passive et general. Arch Gen Med, 1(2), 188–204.

Cabana, M. D., Rand, C. S., Powe, N. R., Wu, A. W., Wilson, M. H., Abboud, P.-A. C., & Rubin, H. R. (1999). Why don’t physicians follow clinical practice guidelines?: A framework for improvement. Jama, 282(15), 1458–1465.

Carrier, M., Le Gal, G., Wells, P. S., Fergusson, D., Ramsay, T., & Rodger, M. A. (2008). Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Annals of Internal Medicine, 149(5), 323–333.

Cook, D., Duffett, M., Lauzier, F., Ye, C., Dodek, P., Paunovic, B., Fowler, R., Kho, M. E., Foster, D., & Stelfox, T. (2014). Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: a multicenter survey. Journal of Critical Care, 29(3), 471-e1.

Fernandes, C. J., Morinaga, L. T. K., Alves, J. L., Castro, M. A., Calderaro, D., Jardim, C. V. P., & Souza, R. (2019). Cancer-associated thrombosis: the when, how and why. European Respiratory Review, 28(151).

Hisada, Y., & Mackman, N. (2017). Cancer-associated pathways and biomarkers of venous thrombosis. Blood, The Journal of the American Society of Hematology, 130(13), 1499–1506.

Horsted, F., West, J., & Grainge, M. J. (2012). Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis.

Ikeda, S., Koga, S., Yamagata, Y., Eguchi, M., Sato, D., Muroya, T., Yonekura, T., Tsuneto, A., Yoshimuta, T., & Koide, Y. (2018). Comparison of the effects of edoxaban, an oral direct factor Xa inhibitor, on venous thromboembolism between patients with and without cancer. Journal of Cardiology, 72(2), 120–127.

Kandemir, E. A., Bayraktar-Ekincioglu, A., & Kilickap, S. (2021). Assessment of adherence to cancer-associated venous thromboembolism guideline and pharmacist’s impact on anticoagulant therapy. Supportive Care in Cancer, 29, 1699–1709.

Khorana, A. A., Francis, C. W., Culakova, E., Kuderer, N. M., & Lyman, G. H. (2007a). Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer: Interdisciplinary International Journal of the American Cancer Society, 110(10), 2339–2346.

Khorana, A. A., Francis, C. W., Culakova, E., Kuderer, N. M., & Lyman, G. H. (2007b). Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. Journal of Thrombosis and Haemostasis, 5(3), 632–634.

Kucher, N., Koo, S., Quiroz, R., Cooper, J. M., Paterno, M. D., Soukonnikov, B., & Goldhaber, S. Z. (2005). Electronic alerts to prevent venous thromboembolism among hospitalized patients. New England Journal of Medicine, 352(10), 969–977.

Lyman, G. H., Khorana, A. A., Falanga, A., Clarke-Pearson, D., Flowers, C., Jahanzeb, M., Kakkar, A., Kuderer, N. M., Levine, M. N., & Liebman, H. (2007). American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. Journal of Clinical Oncology, 25(34), 5490–5505.

Mansfield, A. S., Tafur, A. J., Wang, C. E., Kourelis, T. V, Wysokinska, E. M., & Yang, P. (2016). Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer. Journal of Thrombosis and Haemostasis, 14(9), 1773–1778.

Mukai, M., & Oka, T. (2018). Mechanism and management of cancer-associated thrombosis. Journal of Cardiology, 72(2), 89–93.

Scaglione, L., Piobbici, M., Pagano, E., Ballini, L., Tamponi, G., & Ciccone, G. (2005). Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows. Haematologica, 90(5), 678–684.

Streiff, M. B., Holmstrom, B., Angelini, D., Ashrani, A., Elshoury, A., Fanikos, J., Fertrin, K. Y., Fogerty, A. E., Gao, S., & Goldhaber, S. Z. (2021). Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 19(10), 1181–1201.

Trousseau, A. (1865). Phlegmasia alba dolens. Clinique Medicale de l’Hotel-Dieu de Paris., 94.

Varki, A. (2007). Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood, The Journal of the American Society of Hematology, 110(6), 1723–1729.

Zierler, B. K., Meissner, M. H., Cain, K., & Strandness Jr, D. E. (2002). A survey of physicians’ knowledge and management of venous thromboembolism. Vascular and Endovascular Surgery, 36(5), 367–375.